Challenges in palliative care research; recruitment, attrition and compliance experience from a randomized controlled trial

M S Jordhoy, S Kaasa, Peter Fayers, G Underland, M Ahlner-Elmqvist

Research output: Contribution to journalArticle

222 Citations (Scopus)

Abstract

Randomized controlled trials (RCTs) in palliative cancer care often experience methodological problems. In this paper we discuss issues of major concern, including recruitment, patient attrition and compliance, arising from an RCT that compared comprehensive palliative care to conventional care.

The main criteria for trial entry were incurable malignant disease and a survival expectancy of between 2 and 9 months. Patients' health-related quality of life (HRQL), self-assessed by multi-item questionnaires, was a defined endpoint. The planned number of patients was successfully recruited, although the patients were referred late in the course of their disease so that follow-up tended to be short. Compliance in completing HRQL questionnaires was good up to 1 month before the patient's death; but in the final weeks it was found to drop substantially

Based on our experience, recommendations are given for those planning similar research. Procedures for improving patient recruitment are suggested, stressing the need for local data management, repeated information to referral sources, extensive screening for potentially eligible patients and simple referral routines. Precise inclusion criteria, including prognostic factors other than physicians' estimates of life expectancy, should be used to ensure a sufficient follow-up period. For HRQL assessment, multi-item questionnaires can achieve excellent compliance up to 1 month before patients' death, but in order to evaluate the very final weeks of life we recommend the use of simpler methods.

Original languageEnglish
Pages (from-to)299-310
Number of pages12
JournalPalliative Medicine
Volume13
Issue number4
DOIs
Publication statusPublished - Jun 1999

Keywords

  • clinical trials
  • neoplasms
  • palliative care
  • quality of life
  • research
  • QUALITY-OF-LIFE
  • ILL CANCER-PATIENTS
  • CELL LUNG-CANCER
  • TERMINALLY ILL
  • CLINICAL-TRIALS
  • WORKING PARTY
  • SURVIVAL
  • DISEASE
  • SMOKING
  • LENGTH

Cite this

Challenges in palliative care research; recruitment, attrition and compliance experience from a randomized controlled trial. / Jordhoy, M S ; Kaasa, S ; Fayers, Peter; Underland, G ; Ahlner-Elmqvist, M .

In: Palliative Medicine, Vol. 13, No. 4, 06.1999, p. 299-310.

Research output: Contribution to journalArticle

Jordhoy, M S ; Kaasa, S ; Fayers, Peter ; Underland, G ; Ahlner-Elmqvist, M . / Challenges in palliative care research; recruitment, attrition and compliance experience from a randomized controlled trial. In: Palliative Medicine. 1999 ; Vol. 13, No. 4. pp. 299-310.
@article{e335a02114e34fc887b77712b149f516,
title = "Challenges in palliative care research; recruitment, attrition and compliance experience from a randomized controlled trial",
abstract = "Randomized controlled trials (RCTs) in palliative cancer care often experience methodological problems. In this paper we discuss issues of major concern, including recruitment, patient attrition and compliance, arising from an RCT that compared comprehensive palliative care to conventional care.The main criteria for trial entry were incurable malignant disease and a survival expectancy of between 2 and 9 months. Patients' health-related quality of life (HRQL), self-assessed by multi-item questionnaires, was a defined endpoint. The planned number of patients was successfully recruited, although the patients were referred late in the course of their disease so that follow-up tended to be short. Compliance in completing HRQL questionnaires was good up to 1 month before the patient's death; but in the final weeks it was found to drop substantiallyBased on our experience, recommendations are given for those planning similar research. Procedures for improving patient recruitment are suggested, stressing the need for local data management, repeated information to referral sources, extensive screening for potentially eligible patients and simple referral routines. Precise inclusion criteria, including prognostic factors other than physicians' estimates of life expectancy, should be used to ensure a sufficient follow-up period. For HRQL assessment, multi-item questionnaires can achieve excellent compliance up to 1 month before patients' death, but in order to evaluate the very final weeks of life we recommend the use of simpler methods.",
keywords = "clinical trials, neoplasms, palliative care, quality of life, research, QUALITY-OF-LIFE, ILL CANCER-PATIENTS, CELL LUNG-CANCER, TERMINALLY ILL, CLINICAL-TRIALS, WORKING PARTY, SURVIVAL, DISEASE, SMOKING, LENGTH",
author = "Jordhoy, {M S} and S Kaasa and Peter Fayers and G Underland and M Ahlner-Elmqvist",
year = "1999",
month = "6",
doi = "10.1191/026921699668963873",
language = "English",
volume = "13",
pages = "299--310",
journal = "Palliative Medicine",
issn = "0269-2163",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Challenges in palliative care research; recruitment, attrition and compliance experience from a randomized controlled trial

AU - Jordhoy, M S

AU - Kaasa, S

AU - Fayers, Peter

AU - Underland, G

AU - Ahlner-Elmqvist, M

PY - 1999/6

Y1 - 1999/6

N2 - Randomized controlled trials (RCTs) in palliative cancer care often experience methodological problems. In this paper we discuss issues of major concern, including recruitment, patient attrition and compliance, arising from an RCT that compared comprehensive palliative care to conventional care.The main criteria for trial entry were incurable malignant disease and a survival expectancy of between 2 and 9 months. Patients' health-related quality of life (HRQL), self-assessed by multi-item questionnaires, was a defined endpoint. The planned number of patients was successfully recruited, although the patients were referred late in the course of their disease so that follow-up tended to be short. Compliance in completing HRQL questionnaires was good up to 1 month before the patient's death; but in the final weeks it was found to drop substantiallyBased on our experience, recommendations are given for those planning similar research. Procedures for improving patient recruitment are suggested, stressing the need for local data management, repeated information to referral sources, extensive screening for potentially eligible patients and simple referral routines. Precise inclusion criteria, including prognostic factors other than physicians' estimates of life expectancy, should be used to ensure a sufficient follow-up period. For HRQL assessment, multi-item questionnaires can achieve excellent compliance up to 1 month before patients' death, but in order to evaluate the very final weeks of life we recommend the use of simpler methods.

AB - Randomized controlled trials (RCTs) in palliative cancer care often experience methodological problems. In this paper we discuss issues of major concern, including recruitment, patient attrition and compliance, arising from an RCT that compared comprehensive palliative care to conventional care.The main criteria for trial entry were incurable malignant disease and a survival expectancy of between 2 and 9 months. Patients' health-related quality of life (HRQL), self-assessed by multi-item questionnaires, was a defined endpoint. The planned number of patients was successfully recruited, although the patients were referred late in the course of their disease so that follow-up tended to be short. Compliance in completing HRQL questionnaires was good up to 1 month before the patient's death; but in the final weeks it was found to drop substantiallyBased on our experience, recommendations are given for those planning similar research. Procedures for improving patient recruitment are suggested, stressing the need for local data management, repeated information to referral sources, extensive screening for potentially eligible patients and simple referral routines. Precise inclusion criteria, including prognostic factors other than physicians' estimates of life expectancy, should be used to ensure a sufficient follow-up period. For HRQL assessment, multi-item questionnaires can achieve excellent compliance up to 1 month before patients' death, but in order to evaluate the very final weeks of life we recommend the use of simpler methods.

KW - clinical trials

KW - neoplasms

KW - palliative care

KW - quality of life

KW - research

KW - QUALITY-OF-LIFE

KW - ILL CANCER-PATIENTS

KW - CELL LUNG-CANCER

KW - TERMINALLY ILL

KW - CLINICAL-TRIALS

KW - WORKING PARTY

KW - SURVIVAL

KW - DISEASE

KW - SMOKING

KW - LENGTH

U2 - 10.1191/026921699668963873

DO - 10.1191/026921699668963873

M3 - Article

VL - 13

SP - 299

EP - 310

JO - Palliative Medicine

JF - Palliative Medicine

SN - 0269-2163

IS - 4

ER -